Device and method for drug delivery
First Claim
Patent Images
1. A treatment device for effecting the adsorption of drug in tissue comprising:
- a processor; and
a treatment element comprising a disposable part, a reusable part, at least one identification element configured to determine prior use of the disposable part, and an injection area for administering a plurality of injections of a drug into an injection site of a tissue at a location on the body,wherein the treatment element iscontrolled by the processor,configured to apply a treatment to the tissue at or adjacent the injection site during at least one of before, during and after injection of the drug for a predetermined period of time, andthe treatment is configured to improve the pharmacokinetic and/or pharmacodynamic properties of the injected drug.
1 Assignment
0 Petitions
Accused Products
Abstract
A therapeutic treatment device, system and method for improving administration of a temperature sensitive drug into a tissue on the body of a patient at a drug injection site are disclosed. The device includes a treatment element with a controllable heating element in temperature communicative contact with the tissue adjacent to the drug injection site. The controllable heating element is configured to heat the tissue adjacent to the drug injection site to a controllable temperature but does not heat the injected drug above a predetermined limiting temperature, above which degradation of the injected drug may occur.
-
Citations
17 Claims
-
1. A treatment device for effecting the adsorption of drug in tissue comprising:
-
a processor; and a treatment element comprising a disposable part, a reusable part, at least one identification element configured to determine prior use of the disposable part, and an injection area for administering a plurality of injections of a drug into an injection site of a tissue at a location on the body, wherein the treatment element is controlled by the processor, configured to apply a treatment to the tissue at or adjacent the injection site during at least one of before, during and after injection of the drug for a predetermined period of time, and the treatment is configured to improve the pharmacokinetic and/or pharmacodynamic properties of the injected drug. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
Specification